TICKERNOMICS Sign up
Last Update: 2023-12-21 02:23:23
Futura Medical ( FUM.LSE ) https://www.futuramedical.com
0.35USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United Kingdom
1y
3y
5y
10y
Historical Returns*:
SPY
21.24%
-44.97%
FUM.LSE
SPY
29.39%
FUM.LSE
71.92%
SPY
105.25%
FUM.LSE
375.47%
SPY
198.86%
-64.45%
FUM.LSE
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
111.95
102.03
0.29
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-14.12
1873.77
11.04
-3.34
0.00
0.00
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
11.9576
-106.42
-111.68
1.97
Other Earnings and Cash Flow Stats:
Futura Medical ( FUM.LSE ) Net Income TTM ($MM) is 0.00
Futura Medical ( FUM.LSE ) Operating Income TTM ($MM) is 0.00
Futura Medical ( FUM.LSE ) Owners' Earnings Annual ($MM) is 0.00
Futura Medical ( FUM.LSE ) Current Price to Owners' Earnings ratio is 0.00
Futura Medical ( FUM.LSE ) EBITDA TTM ($MM) is 0.00
Futura Medical ( FUM.LSE ) EBITDA Margin is 0.00%
Capital Allocation:
Futura Medical ( FUM.LSE ) has paid 0.00 dividends per share and bought back -11.77493 million shares in the past 12 months
Futura Medical ( FUM.LSE ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
Futura Medical ( FUM.LSE ) Interest-bearing Debt ($MM) as of last quarter is 0
Futura Medical ( FUM.LSE ) Annual Working Capital Investments ($MM) are -6
Futura Medical ( FUM.LSE ) Book Value ($MM) as of last quarter is 10
Futura Medical ( FUM.LSE ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
Futura Medical ( FUM.LSE ) has 9 million in cash on hand as of last quarter
Futura Medical ( FUM.LSE ) has 2 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Futura Medical ( FUM.LSE ) has 299 common shares outstanding as of last quarter
Futura Medical ( FUM.LSE ) has 0 million USD of preferred stock value
Academic Scores:
Futura Medical ( FUM.LSE ) Altman Z-Score is 16.11 as of last quarter
Futura Medical ( FUM.LSE ) Piotroski Score is 0.00 as of last quarter
Corporate Governance:
Futura Medical ( FUM.LSE ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Futura Medical ( FUM.LSE ) for the amount of $ on
41.69% of Futura Medical ( FUM.LSE ) is held by insiders, and 45.70% is held by institutions
Futura Medical ( FUM.LSE ) went public on 1970-01-01
Other Futura Medical ( FUM.LSE ) financial metrics:
FCF:-3.50
Unlevered Free Cash Flow:0.00
EPS:0.00
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:0.00
Beta:1.97
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Futura Medical ( FUM.LSE ) :
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.